Literature DB >> 6115626

Recurrent Churg-Strauss vasculitis. With exophthalmos, hearing loss, nasal obstruction, amyloid deposits, hyperimmunoglobulinemia E, and circulating immune complexes.

S Sale, R Patterson.   

Abstract

Churg-Strauss vasculitis in remission for 4 1/2 years recurred, with new, previously undescribed features, after a lapse in corticosteroid therapy. Bilateral exophthalmos, unilateral hearing loss, and nasal obstruction accompanied fever, severe asthma, and palpable purpura. Leukocytosis with eosinophilia, an elevated ESR, hyperimmunoglobulinemia E, an pulmonary infiltrates were seen again. Circulating immune complexes were detected, and microamyloid deposits were found in the conjunctiva and skin. All clinical and laboratory manifestations responded to corticosteroid therapy. Monitoring the levels of IgE may add a diagnostic and prognostic feature to the classification of necrotizing vasculitides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115626     DOI: 10.1001/archinte.141.10.1363

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

Review 2.  [Ocular manifestations of Churg-Strauss syndrome: review article and case report].

Authors:  A Atili; C Richter; E Bahn; H H Rustenbeck; M Schittkowski
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

3.  [Diagnosis and therapy of Churg-Strauss allergic granulomatosis].

Authors:  P Berlit; B Storch; H P Schmitt
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

4.  Increased Risk of Sensorineural Hearing Loss as a Result of Exposure to Air Pollution.

Authors:  Kuang-Hsi Chang; Stella Chin-Shaw Tsai; Chang-Yin Lee; Ruey-Hwang Chou; Hueng-Chuen Fan; Frank Cheau-Feng Lin; Cheng-Li Lin; Yi-Chao Hsu
Journal:  Int J Environ Res Public Health       Date:  2020-03-17       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.